LLY |
Eli Lilly and Company |
864.12B |
18.10% |
|
|
|
|
|
909.19 |
0.47% |
32.30% |
17.67% |
---|
NVS |
Novartis AG |
227.30B |
6.60% |
|
|
|
|
|
116.18 |
0.18% |
20.98% |
49.72% |
---|
AMGN |
Amgen Inc. |
181.10B |
6.43% |
|
|
|
|
|
337.03 |
1.23% |
26.21% |
30.95% |
---|
AZN |
AstraZeneca PLC |
245.89B |
6.11% |
|
|
|
|
|
79.31 |
0.92% |
22.04% |
41.59% |
---|
USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.75% |
|
|
|
|
|
|
|
|
|
---|
BMY |
Bristol-Myers Squibb Company |
99.88B |
5.22% |
|
|
|
|
|
49.27 |
-0.96% |
31.12% |
70.51% |
---|
JNJ |
Johnson & Johnson |
396.64B |
4.98% |
|
|
|
|
|
164.77 |
-0.83% |
20.29% |
48.89% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
125.74B |
4.89% |
|
|
|
|
|
1,159.74 |
1.84% |
25.78% |
44.23% |
---|
MRK |
Merck & Co., Inc. |
295.70B |
4.70% |
|
|
|
|
|
116.66 |
-1.67% |
21.19% |
30.70% |
---|
PFE |
Pfizer Inc. |
168.90B |
4.36% |
|
|
|
|
|
29.81 |
0.18% |
27.87% |
32.32% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
35.73B |
4.28% |
|
|
|
|
|
278.30 |
1.89% |
36.97% |
23.68% |
---|
BIIB |
Biogen Inc. |
29.54B |
3.72% |
|
|
|
|
|
202.79 |
2.63% |
27.31% |
24.65% |
---|
ALKS |
Alkermes plc |
4.67B |
3.65% |
|
|
|
|
|
28.34 |
1.83% |
37.86% |
56.93% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
6.77B |
3.55% |
|
|
|
|
|
42.93 |
1.35% |
35.48% |
32.80% |
---|
GSK |
GSK plc |
85.40B |
2.87% |
|
|
|
|
|
41.88 |
-1.31% |
22.53% |
55.93% |
---|
CRSP |
CRISPR Therapeutics AG |
4.32B |
2.82% |
|
|
|
|
|
50.75 |
2.34% |
56.34% |
13.85% |
---|
NTLA |
Intellia Therapeutics, Inc. |
2.37B |
1.78% |
|
|
|
|
|
23.30 |
3.46% |
66.71% |
33.82% |
---|
BCYC |
Bicycle Therapeutics plc |
1.74B |
1.74% |
|
|
|
|
|
25.31 |
3.90% |
113.45% |
52.53% |
---|
BEAM |
Beam Therapeutics Inc. |
2.16B |
1.37% |
|
|
|
|
|
26.19 |
2.67% |
47.60% |
34.47% |
---|
REPL |
Replimune Group, Inc. |
767.59M |
0.91% |
|
|
|
|
|
11.24 |
1.40% |
74.66% |
17.82% |
---|
HLN |
Haleon plc |
47.74B |
0.86% |
|
|
|
|
|
10.47 |
-0.76% |
90.45% |
0.56% |
---|
VNDA |
Vanda Pharmaceuticals Inc. |
271.05M |
0.78% |
|
|
|
|
|
4.65 |
-6.06% |
63.97% |
50.45% |
---|
GALT |
Galectin Therapeutics Inc. |
177.18M |
0.77% |
|
|
|
|
|
2.8450 |
4.98% |
425.57% |
62.91% |
---|
EDIT |
Editas Medicine, Inc. |
330.73M |
0.65% |
|
|
|
|
|
4.01 |
3.35% |
179.61% |
63.33% |
---|
LTRN |
Lantern Pharma Inc. |
45.92M |
0.60% |
|
|
|
|
|
4.27 |
9.09% |
243.54% |
29.41% |
---|
GEHC |
GE HealthCare Technologies Inc. |
41.27B |
0.50% |
|
|
|
|
|
90.38 |
2.09% |
27.99% |
32.93% |
---|
SDZNY |
Sandoz Group AG |
|
0.48% |
|
|
|
|
|
|
|
|
|
---|
TSVT |
2seventy bio, Inc. |
250.28M |
0.45% |
|
|
|
|
|
4.86 |
2.97% |
352.01% |
35.07% |
---|
ALLO |
Allogene Therapeutics, Inc. |
627.34M |
0.28% |
|
|
|
|
|
3.00 |
4.17% |
176.39% |
46.90% |
---|
Cash&Other |
Cash & Other |
|
0.27% |
|
|
|
|
|
|
|
|
|
---|
VTRS |
Viatris Inc. |
14.42B |
0.25% |
|
|
|
|
|
12.09 |
1.55% |
30.86% |
40.63% |
---|
BLUE |
bluebird bio, Inc. |
96.67M |
0.12% |
|
|
|
|
|
0.4985 |
0.71% |
236.87% |
83.03% |
---|
PACB |
Pacific Biosciences of California, Inc. |
550.32M |
0.10% |
|
|
|
|
|
2.0193 |
4.63% |
237.03% |
53.57% |
---|
MURA |
Mural Oncology plc |
58.84M |
0.04% |
|
|
|
|
|
3.45 |
0.11% |
N/A |
47.46% |
---|
SLRX |
Salarius Pharmaceuticals, Inc. |
2.47M |
0.04% |
|
|
|
|
|
1.7147 |
-3.12% |
N/A |
N/A |
---|
2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
---|